Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A 6-Year Follow-Up of Fracture Incidence and Volumetric Bone Mineral Density Development in Girls With Turner Syndrome

O. Soucek, E. Schönau, J. Lebl, J. Willnecker, Z. Hlavka, Z. Sumnik,

. 2018 ; 103 (3) : 1188-1197.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024401

Context: Patients with Turner syndrome (TS) are at risk for osteoporotic fractures. Objective: The aims of this study were to assess the incidence of clinically important fractures in girls with TS and prospectively describe the development of volumetric bone mineral density (BMD). Design: Peripheral quantitative computerized tomography (pQCT) of the radius every other year over the 6 years of observation. Setting: Government-funded university referral center. Participants: Thirty-two girls with TS, aged 6 to 16 years, were included in the analyses. Fracture incidence was compared with the data in the general population. Bone density and strength were compared with data from 185 healthy girls. Outcomes: The main clinical outcome was the fracture occurrence. The secondary outcomes were the changes in Z-scores of the bone parameters. Results: Three girls with TS sustained four fractures during 6 years of observation. The fracture rate in TS was not substantially higher than the downward-biased fracture-rate estimate from age-matched, healthy controls (P = 0.48). Whereas the trabecular BMD Z-score decreased with age (β estimate -0.21 ± 0.04, P < 0.001), total bone cross-sectional area correspondingly increased (+0.16 ± 0.04, P < 0.001), which led to normal bone strength. A positive history of incident fractures was not significantly associated with any of the pQCT-derived bone parameters. Conclusions: Current pediatric TS patients that are treated with growth hormone and estrogens are not at risk for osteoporotic fractures. Low BMD in TS may be counterweighted by enlarged bone radius, which leads to normal bone strength at the appendicular skeleton.

000      
00000naa a2200000 a 4500
001      
bmc18024401
003      
CZ-PrNML
005      
20180718112432.0
007      
ta
008      
180709s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1210/jc.2017-02381 $2 doi
035    __
$a (PubMed)29300907
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Soucek, Ondrej $u Department of Pediatrics, Second Medical Faculty, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
245    12
$a A 6-Year Follow-Up of Fracture Incidence and Volumetric Bone Mineral Density Development in Girls With Turner Syndrome / $c O. Soucek, E. Schönau, J. Lebl, J. Willnecker, Z. Hlavka, Z. Sumnik,
520    9_
$a Context: Patients with Turner syndrome (TS) are at risk for osteoporotic fractures. Objective: The aims of this study were to assess the incidence of clinically important fractures in girls with TS and prospectively describe the development of volumetric bone mineral density (BMD). Design: Peripheral quantitative computerized tomography (pQCT) of the radius every other year over the 6 years of observation. Setting: Government-funded university referral center. Participants: Thirty-two girls with TS, aged 6 to 16 years, were included in the analyses. Fracture incidence was compared with the data in the general population. Bone density and strength were compared with data from 185 healthy girls. Outcomes: The main clinical outcome was the fracture occurrence. The secondary outcomes were the changes in Z-scores of the bone parameters. Results: Three girls with TS sustained four fractures during 6 years of observation. The fracture rate in TS was not substantially higher than the downward-biased fracture-rate estimate from age-matched, healthy controls (P = 0.48). Whereas the trabecular BMD Z-score decreased with age (β estimate -0.21 ± 0.04, P < 0.001), total bone cross-sectional area correspondingly increased (+0.16 ± 0.04, P < 0.001), which led to normal bone strength. A positive history of incident fractures was not significantly associated with any of the pQCT-derived bone parameters. Conclusions: Current pediatric TS patients that are treated with growth hormone and estrogens are not at risk for osteoporotic fractures. Low BMD in TS may be counterweighted by enlarged bone radius, which leads to normal bone strength at the appendicular skeleton.
650    _2
$a mladiství $7 D000293
650    _2
$a kostní denzita $x účinky léků $7 D015519
650    _2
$a dítě $7 D002648
650    _2
$a estrogeny $x terapeutické užití $7 D004967
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a růstový hormon $x terapeutické užití $7 D013006
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a osteoporotické fraktury $x epidemiologie $x etiologie $7 D058866
650    _2
$a radius $x diagnostické zobrazování $7 D011884
650    _2
$a rizikové faktory $7 D012307
650    _2
$a časové faktory $7 D013997
650    _2
$a počítačová rentgenová tomografie $x metody $7 D014057
650    _2
$a Turnerův syndrom $x komplikace $x farmakoterapie $x patofyziologie $7 D014424
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Schönau, Eckhard $u Department of Pediatrics, University Hospital Cologne and Cologne University, Cologne, Germany.
700    1_
$a Lebl, Jan $u Department of Pediatrics, Second Medical Faculty, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Willnecker, Johannes $u Stratec Medizintechnik GmbH, Pforzheim, Germany.
700    1_
$a Hlavka, Zdenek $u Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Sumnik, Zdenek $u Department of Pediatrics, Second Medical Faculty, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
773    0_
$w MED00002582 $t The Journal of clinical endocrinology and metabolism $x 1945-7197 $g Roč. 103, č. 3 (2018), s. 1188-1197
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29300907 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180718112732 $b ABA008
999    __
$a ok $b bmc $g 1316532 $s 1021322
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 103 $c 3 $d 1188-1197 $i 1945-7197 $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab $x MED00002582
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...